AHB
Sector: F-AI - Other Food • Location: China
Source: IFC Project Disclosures
Anhui Huaheng Biotechnology Co., Ltd. (AHB or the Company) is a leading manufacturer of amino acids and other bio-based products in the People’s Republic of China (PRC). IFC is proposing to provide up to RMB 500 million (equivalent to US$70.5 million) in the form of a Green Loan (the Loan) to Qinhuangdao Huaheng Bioengineering Co., Ltd. (QHB), a wholly-owned subsidiary of AHB. The IFC proceeds wil
- Status
- Prospective
- Sector
- F-AI - Other Food
- Location
- China
- Updated
- 19 Nov 2026
- Source
- IFC Project Disclosures
ConstructChat
Ask ConstructChat about AHB
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | pending |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | Anhui Huaheng Biotechnology Co., Ltd. (AHB or the Company) is a leading manufacturer of amino acids and other bio-based products in the People’s Republic of China (PRC). IFC is proposing to provide up to RMB 500 million (equivalent to US$70.5 million) in the form of a Green Loan (the Loan) to Qinhuangdao Huaheng Bioengineering Co., Ltd. (QHB), a wholly-owned subsidiary of AHB. The IFC proceeds will be used to fund the capex and working capital needs of malic acid and L-Tryptophan production (the Project). |
Original sector | F-AI - Other Food |
Location
Country | China |
Source
Source | IFC Project Disclosures |
URL |
More Details
Record type | Project |
Article published date | 2026-09-09 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
